Results 151 to 160 of about 3,628 (221)

Bannakunin: a dual-target Kunitz inhibitor bridging anticoagulation (FXa/XIIa) and anti-platelet (α2β1/P2Y12) pathways. [PDF]

Cell Mol Biol Lett
He M, He Y, Feng X, Li Z, Lin T, Yang J, Luo H, Mu L, Yang H, Wu J.   +9 more
europepmc   +1 more source

Cangrelor in Patients Undergoing Percutaneous Coronary Intervention After Out-of-Hospital Cardiac Arrest. [PDF]

J Clin Med
Ferlini M, Raone L, Bendotti S, Currao A, Primi R, Bongiorno A, Fava C, Dall'Oglio L, Adamo M, Ghiraldin D, Marino M, Dossena C, Baldo A, Maffeo D, Kajana V, Affinito S, Baldi E, De Luca L, Savastano S.   +18 more
europepmc   +1 more source

Relationship Between the Current Definitions of Periprocedural Myocardial Infarction and Clinical Outcomes Following Percutaneous Coronary Revascularization. [PDF]

Rev Cardiovasc Med
Paolucci L, Nardi G, Lombardi M, Occhipinti G, Mangiacapra F, Vergallo R, Musto C, Colaiori I, Briguori C, Gabrielli D, Felice F.   +10 more
europepmc   +1 more source

A Patient Presenting with Joint Deformities and ST-Elevation Myocardial Infarction. [PDF]

Diagnostics (Basel)
Dąbrowski EJ, Kozłowska WU, Lipska PO, Kożuch M, Dobrzycki S.   +4 more
europepmc   +1 more source

Cangrelor use in a pediatric patient with aneurysmal subarachnoid hemorrhage. [PDF]

Neuroradiol J
Russo R, Molinaro S, Mistretta F, Gava U, Morana G, Peretta P, Del Borrello G, Zeppa P, Bergui M.   +8 more
europepmc   +1 more source

Repurposing FDA-Approved Agents to Develop a Prototype Helicobacter pylori Shikimate Kinase (HPSK) Inhibitor: A Computational Approach Using Virtual Screening, MM-GBSA Calculations, MD Simulations, and DFT Analysis. [PDF]

Pharmaceuticals (Basel)
Al Khzem AH, Shoaib TH, Mukhtar RM, Alturki MS, Gomaa MS, Hussein D, Tawfeeq N, Bano M, Sarafroz M, Alzahrani R, Alghamdi H, Rants'o TA.   +11 more
europepmc   +1 more source

Bleeding in Antiplatelet Therapy: A Narrative Review of Clinical Evidence and the Roles of Pharmacists and Nurses. [PDF]

Rev Cardiovasc Med
Xu F, Zhang ZH, Li LC, Mao KL, Huang ZY.
europepmc   +1 more source

Antithrombotic Therapy in the Elderly with Cardiovascular Disease: Walking the Tightrope Between Efficacy and Bleeding Risk-A Narrative Review. [PDF]

J Clin Med
Sciahbasi A, Minardi S, Salvi N, Infusino F, Granatelli A.   +4 more
europepmc   +1 more source

Antithrombotic Therapy in Acute Coronary Syndrome Patients with End-Stage Renal Disease: Navigating Efficacy and Safety. [PDF]

J Clin Med
Abdeldayem T, Jeyalan V, Hayat A, Memon S, Farag M, Egred M.   +5 more
europepmc   +1 more source